This company has been acquired
DICE Therapeutics Dirección
Dirección controles de criterios 2/4
We currently do not have sufficient information about the CEO.
Información clave
J. Judice
Chief Executive Officer (CEO)
US$5.8m
Compensación total
| Porcentaje del salario del CEO | 9.4% |
| Permanencia del CEO | 10yrs |
| Participación del CEO | 1.7% |
| Permanencia media de la dirección | 2.6yrs |
| Promedio de permanencia en la Junta Directiva | 2.7yrs |
Actualizaciones recientes de la dirección
Recent updates
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14
DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct 11Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11DICE Therapeutics GAAP EPS of -$0.58
Aug 11DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs
Jul 18Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$104m |
| Mar 31 2023 | n/a | n/a | -US$91m |
| Dec 31 2022 | US$6m | US$540k | -US$84m |
| Sep 30 2022 | n/a | n/a | -US$77m |
| Jun 30 2022 | n/a | n/a | -US$74m |
| Mar 31 2022 | n/a | n/a | -US$59m |
| Dec 31 2021 | US$6m | US$465k | -US$49m |
| Sep 30 2021 | n/a | n/a | -US$40m |
| Jun 30 2021 | n/a | n/a | -US$29m |
| Mar 31 2021 | n/a | n/a | -US$27m |
| Dec 31 2020 | US$637k | US$437k | -US$24m |
Compensación vs. Mercado: J.'s total compensation ($USD5.77M) is about average for companies of similar size in the US market ($USD5.11M).
Compensación vs. Ingresos: J.'s compensation has increased whilst the company is unprofitable.
CEO
J. Judice (59 yo)
10yrs
Permanencia
US$5,773,577
Compensación
Dr. J. Kevin Judice, Ph D., founded DiCE Molecules SV, Inc. (formerly known as DiCE Molecules Corp). and serves as its Chief Executive Officer, President and Secretary. Dr. Judice has extensive experience...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 10yrs | US$5.77m | 1.67% $ 38.0m | |
| Chief Business & Financial Officer | 5.7yrs | US$2.67m | 0.41% $ 9.4m | |
| Chief Medical Officer | 3yrs | US$2.72m | 0.32% $ 7.2m | |
| Chief Scientific Officer | 2.2yrs | US$714.79k | 0.31% $ 7.0m | |
| General Counsel | 1.4yrs | sin datos | sin datos | |
| Senior Vice President of CMC | 2.2yrs | sin datos | sin datos | |
| Senior Vice President of Medicinal Chemistry | no data | sin datos | sin datos |
2.6yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: DICE's management team is considered experienced (2.6 years average tenure).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | no data | US$5.77m | 1.67% $ 38.0m | |
| Independent Director | 2.8yrs | US$264.90k | 0.10% $ 2.4m | |
| Independent Chairman of the Board | 7.7yrs | US$371.88k | 0.018% $ 400.6k | |
| Independent Director | 2.8yrs | US$264.90k | 0.086% $ 1.9m | |
| Independent Director | 1.4yrs | US$552.51k | 0% $ 0 | |
| Independent Director | 2.7yrs | US$231.45k | sin datos | |
| Independent Director | 1.4yrs | US$552.51k | 0% $ 0 |
2.7yrs
Permanencia media
59yo
Promedio de edad
Junta con experiencia: DICE's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.